查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392099

全球恐慌發作治療市場：依藥物類別、途徑、配銷通路及地區分類

Global Panic Attack Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球恐慌症治療市場預計將從 2023 年的 21.4 億美元增至 2030 年的 63.4 億美元，預測期內複合年成長率為 16.8%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 21.4億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 16.80% 2030年市場規模預測 63.4億美元
圖 1. 2023 年恐慌症治療全球市場佔有率（依地區分類）
全球恐慌症治療市場-IMG1

恐慌發作是突然而強烈的恐懼或痛苦的發作，可能會使經歷這些症狀的人變得虛弱。這些發作通常在毫無徵兆的情況下發生，並可能導致心悸、氣短和胸痛等身體症狀。恐慌發作的治療重點是緩解症狀、減少發作頻率和提高整體生活品質。

市場動態：

全球恐慌症治療市場預計在不久的將來將出現顯著成長。全球市場的成長是由多種因素推動的，其中包括全球恐慌發作的日益普及。人們對心理健康的認知不斷提高，對恐慌發作的接受度和理解不斷增強，也促進了市場的成長。醫療技術和治療性介入的進步正在開發更有效的恐慌症治療方法。例如，根據美國焦慮和憂鬱症協會（ADAA）的數據，2020年，焦慮症是美國最常見的精神疾病，每年影響美國近4000萬（18.1%）18歲及以上成年人。根據同一來源，每年，整體焦慮症 (GAD) 影響 680 萬成年人（占美國人口的 3.1%），恐慌症 (PD) 影響 600 萬成年人（占美國人口的 2.7%）。

然而，也存在著限制市場成長的因素。這個市場的主要課題之一是與心理健康問題（包括恐慌發作）相關的恥辱。這種恥辱常常阻止個人尋求幫助和治療。此外，治療恐慌症的高昂費用和一些地區的報銷政策不佳也是市場成長的潛在障礙。

儘管存在這些課題，市場上仍然存在一些機會。對能夠有效控制恐慌發作的個體化、標靶治療的需求不斷成長。此外，虛擬實境技術和人工智慧在恐慌症治療中的結合有望為市場拓展開闢新的途徑。製藥主要企業增加對研發活動的投資預計將促進該市場的創新並創造成長機會。

本研究的主要特點

  • 該報告對全球恐慌症治療市場進行了詳細分析，包括以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
  • 該報告揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 該報告提供了有關市場促進因素、抑制因素因素、機會、新產品發布和核准、市場趨勢和促進因素、區域前景、主要企業採取的競爭策略等的重要考察。
  • GlaxoSmithKline plc.、F. Hoffmann-La Roche Ltd、Teva Pharmaceutical Industries Ltd.、禮來公司、Bristol-Myers Squibb Company、阿斯特捷利康、輝瑞公司、Johnson & Johnson Services, Inc.、Bausch Health Companies Inc.、H根據公司亮點、產品系列、主要亮點、財務實績和策略，介紹靈北 A/S 等全球恐慌症治療市場的主要公司。
  • 該報告的見解使行銷人員和負責人能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出資訊的決策。
  • 全球恐慌症治療市場報告針對各種相關人員，如行業投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以從全球恐慌症治療市場分析中使用的各種策略矩陣中受益，以促進決策。

目錄

第1章 研究目的與假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
  • 焦慮和恐慌發作的盛行率增加
    • 抑制因素
  • 藥物副作用和安全問題
    • 機會
  • 遠端醫療和電子治療的使用增加
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章全球恐慌症治療市場－冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章全球恐慌症治療市場，依藥物類別，2018-2030

  • 介紹
  • 抗憂鬱症
  • 抗焦慮藥
  • CGRP拮抗劑
  • 其他

第6章全球恐慌症治療市場，依給藥途徑，2018-2030

  • 介紹
  • 口服
  • 靜脈
  • 肌肉注射
  • 舌下
  • 其他

第7章全球恐慌症治療市場，依配銷通路，2018-2030

  • 介紹
  • 醫院藥房
  • 零售藥房
  • 線上藥房

第8章全球恐慌症治療市場，依地區，2018-2030

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章競爭形勢

  • GlaxoSmithKline plc.
  • Hoffmann-La Roche Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Bausch Health Companies Inc.
  • Lundbeck A/S

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6460

Global Panic Attack Treatment Market is expected to reach US$ 6.34 Bn by 2030, from US$ 2.14 Bn in 2023, exhibiting a CAGR of 16.8% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.14 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 16.80% 2030 Value Projection: US$ 6.34 Bn
Figure 1. Global Panic Attack Treatment Market Share (%), By Region, 2023
Global Panic Attack Treatment Market - IMG1

Panic attacks are intense episodes of sudden fear or distress that can be debilitating for individuals who experience them. These attacks often come without warning, and can cause physical symptoms such as heart palpitations, shortness of breath, and chest pain. Panic attack treatment focuses on relieving symptoms, reducing the frequency of attacks, and improving overall quality of life.

Market Dynamics:

Global panic attack treatment market is expected to witness significant growth in the near future. The global market growth is driven by several factors including the increasing prevalence of panic disorders worldwide. Rising awareness about mental health, coupled with the growing acceptance and understanding of panic attacks, are also contributing to market growth. Advancements in medical technology and therapeutic interventions have led to the development of more effective treatments for panic attacks. For instance, according to the Anxiety and Depression Association of America (ADAA), in 2020, anxiety disorders are the most common mental illness in the U.S. that affects nearly 40 million adults (18.1%) in the U.S. aged 18 years and older, every year. According to the same source, generalized anxiety disorder (GAD) affects 6.8 million adults, or 3.1% of the U.S. population and panic disorder (PD) affects 6 million adults, or 2.7% of the U.S. population, each year.

However, there are certain factors that may restrain the market growth. One of the key challenges in this market is the stigma associated with mental health issues including panic attacks. This stigma often prevents individuals from seeking help and treatment. Moreover, the high cost of panic attack treatments and a lack of reimbursement policies in some regions are also potential barriers to the market growth.

Despite these challenges, several opportunities exist in the market. There is a growing demand for personalized and targeted therapies that can effectively manage panic attacks. Moreover, the integration of virtual reality technology and artificial intelligence in panic attack treatment is expected to open new avenues for market expansion. Increasing investments in research and development activities by key players in the pharmaceutical industry are likely to boost innovation in this market and create growth opportunities.

Key Features of the Study:

  • This report provides in-depth analysis of the global panic attack treatment market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key players in the global panic attack treatment market likeGlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., and H. Lundbeck A/S are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies
  • Insights from this report would allow marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics
  • The global panic attack treatment market report caters to various stakeholders, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts in the industry
  • Stakeholders can benefit from various strategy matrices used in analyzing the global panic attack treatment market, which would facilitate ease in decision-making

Detailed Segmentation:

  • By Drug Class
    • Antidepressants
    • Anti-anxiety Drugs
    • CGRP Antagonists
    • Others
  • By Route of Administration
    • Oral
    • Intravenous
    • Intramuscular
    • Sublingual
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top companies in Global Panic Attack Treatment Market:
    • GlaxoSmithKline plc.
    • F.Hoffmann-La Roche Ltd
    • Teva Pharmaceutical Industries Ltd.
    • Eli Lilly and Company
    • Bristol-Myers Squibb Company
    • AstraZeneca
    • Pfizer Inc.
    • Johnson & Johnson Services, Inc.
    • Bausch Health Companies Inc.
    • Lundbeck A/S

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of anxiety and panic disorders
    • Restraints
  • Side effects and safety issues with medications
    • Opportunities
  • Growing use of telemedicine and e-therapies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Panic Attack Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Panic Attack Treatment Market, By Drug Class, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Antidepressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Anti-anxiety Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • CGRP Antagonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Panic Attack Treatment Market, By Route of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Panic Attack Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Panic Attack Treatment Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,( US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • GlaxoSmithKline plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Bausch Health Companies Inc.
  • Lundbeck A/S
  • Analyst Views

10. Section

  • Research Methodology
  • About us